| Least squares mean changes (95% confidence interval) | p-values (Erenumab vs Placebo) | |||
---|---|---|---|---|---|
Erenumab 70 mg | Erenumab 140 mg | Placebo | Erenumab 70 mg | Erenumab 140 mg | |
Physical function | −13.7 (−15.5, −11.9) | −15.1 (−17.0, −13.3) | −9.4 (−11.3, −7.6) | <0.001 | <0.001 |
Usual activities | −12.3 (−13.9, −10.6) | −13.4 (−15.1, −11.8) | −8.3 (−10.0, −6.6) | <0.001 | <0.001 |
Social function | −13.2 (−14.9, −11.4) | −14.5 (−16.2, −12.8) | −9.5 (−11.3, −7.7) | 0.003 | <0.001 |
Emotional function | −16.4 (−18.4, −14.5) | −18.4 (−20.3, −16.5) | −11.2 (−13.1, −9.2) | <0.001 | <0.001 |